These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2250943)

  • 1. [Role of growth hormone in proliferative diabetic retinopathy. Clinical and immunohistochemical aspects].
    Negre F; Fredj-Reygrobellet D; Harroche S; Taieb JC
    Ophtalmologie; 1990; 4(1):56-9. PubMed ID: 2250943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
    Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
    Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance and detection of insulin-like growth factor I in vitreous with proliferative retinal diseases by radioimmunoassay].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):122-5. PubMed ID: 7656720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy.
    Loukovaara S; Immonen IJ; Koistinen R; Rutanen EM; Hiilesmaa V; Loukovaara M; Kaaja RJ
    J Diabetes Complications; 2005; 19(5):297-304. PubMed ID: 16112506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy].
    Asensio-Sánchez VM; Gómez-Ramírez V; Morales-Gómez I
    Arch Soc Esp Oftalmol; 2008 Mar; 83(3):169-72. PubMed ID: 18311675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes.
    Ulbig MW; Wolfensberger TJ; Hiscott P; Ationu A; Carter ND; Gregor ZJ
    Ger J Ophthalmol; 1995 Sep; 4(5):264-8. PubMed ID: 7496335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein-1 levels in diabetic proliferative retinopathy.
    Hopkins KD; Brart DO; Russell-Jones DL; Chignell AH; Sönksen PH
    Horm Metab Res; 1993 Jun; 25(6):331-2. PubMed ID: 7688338
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.
    Lee HC; Lee KW; Chung CH; Chung YS; Lee EJ; Lim SK; Kim KR; Huh KB; Lee SC; Kwon OW
    Diabetes Res Clin Pract; 1994 Jun; 24(2):85-8. PubMed ID: 7956713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone hypothesis - 2005 revision.
    Frystyk J
    Horm Metab Res; 2005 Apr; 37 Suppl 1():44-8. PubMed ID: 15918110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
    Zhou H; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
    George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
    Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
    Liinamaa MJ; Savolainen MJ
    Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.